- Home
- PACB vs NMAI Comparison
PACB vs NMAI Comparison
Compare PACB & NMAI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | PACB | NMAI |
|---|---|---|
| Founded | 2000 | 2021 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Laboratory Analytical Instruments | Investment Managers |
| Sector | Industrials | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 419.8M | 455.9M |
| IPO Year | 2010 | N/A |
Fundamental Metrics
Financial Performance| Metric | PACB | NMAI |
|---|---|---|
| Price | $1.60 | $13.67 |
| Analyst Decision | Hold | |
| Analyst Count | 3 | 0 |
| Target Price | ★ $1.67 | N/A |
| AVG Volume (30 Days) | ★ 6.4M | 94.0K |
| Earning Date | 05-07-2026 | 01-01-0001 |
| Dividend Yield | N/A | ★ 13.14% |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ 0.64 |
| Revenue | ★ $93,468,000.00 | N/A |
| Revenue This Year | $11.32 | N/A |
| Revenue Next Year | $12.14 | N/A |
| P/E Ratio | ★ N/A | $21.17 |
| Revenue Growth | ★ 3.04 | N/A |
| 52 Week Low | $0.85 | $11.80 |
| 52 Week High | $2.73 | $13.96 |
Technical Indicators
Market Signals| Indicator | PACB | NMAI |
|---|---|---|
| Relative Strength Index (RSI) | 54.47 | 63.26 |
| Support Level | $1.52 | $13.43 |
| Resistance Level | $1.78 | $13.86 |
| Average True Range (ATR) | 0.12 | 0.26 |
| MACD | 0.01 | 0.04 |
| Stochastic Oscillator | 59.18 | 88.84 |
Price Performance
Historical ComparisonAbout PACB Pacific Biosciences of California Inc.
Pacific Biosciences of California Inc is a biotechnology company focused on designing, developing, and manufacturing sequencing solutions that enable scientists and clinical researchers to improve their understanding of the genome and ultimately, resolve genetically complex problems. It operates in, one reportable segment: the development, manufacturing, and marketing of an integrated platform for genetic analysis. The majority of the company's revenue is derived from Americas, followed by Europe Middle East, and Africa and Asia-Pacific.
About NMAI Nuveen Multi-Asset Income Fund of Beneficial Interest
Nuveen Multi-Asset Income Fund is a closed-end management investment company. The Fund dynamically invests in a portfolio of equity and debt securities of issuers located around the world. This dynamic investment uses a risk-based framework in which any amount can be allocated to an asset-class at any time. The Fund's investment objective is to provide total return through high current income and capital appreciation.